Thus, our findings suggest that paclitaxel induces UBC13 down-regulation, which facilitates cell resistance to paclitaxel, and a pathway consisting of DNMT1, CHFR, and Aurora A probably participates in UBC13 regulation of the sensitivity to paclitaxel in ovarian cancer cells. Here, DNMT1 is linked to ovarian cancer.